Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Organ Weight / Spleen weight
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.311
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / Neutrophils
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.966
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / Transitional B Cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0989
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Monocyte differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0345
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Platelet count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.111
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.343
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / Monocytes
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.668
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.136
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.257
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Monocyte cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00593
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / Eosinophils
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.903
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.234
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / Follicular B Cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.493
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD25- T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.804
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Mean platelet volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.815
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Eosinophil differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.831
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.599
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.587
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DP T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.626
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.454
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 NKT cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.553
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0865
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.356
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Eosinophil cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.879
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Mean cell volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.593
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.776
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / cDCs
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.351
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.983
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Basophil differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
9.90×10-05
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.296
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.637
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Basophil cell count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
6.74×10-05
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / B1B Cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.877
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.296
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Red blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.433
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:7m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.506
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Hematocrit
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.626
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.678
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.817
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / B2B Cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.562
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.775
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.290
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.290
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / MZB
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.459
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Neutrophil differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.679
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Red blood cell distribution width
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.893
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.795
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.252
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.851
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Neutrophil cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.206
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.541
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
3f:6m
|
|
|
NotProcessed |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.222
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.910
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Lymphocyte cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.647
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.847
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.296
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.222
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / Lymphocyte differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.237
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.643
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / T cells (panel A)
|
HET
|
3f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.745
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / B Cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.255
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.364
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
3f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.758
|
Successful |
Ahcytm1b(EUCOMM)Hmgu
|
TCP
|
Hematology / White blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.276
|
Successful |